Volume 22, Issue 12 pp. 2288-2291

Tumor size is associated with the systemic inflammatory response but not survival in patients with primary operable colorectal cancer

Joseph EM Crozier

Joseph EM Crozier

University Department of Surgery, Royal Infirmary, Glasgow, UK

Search for more papers by this author
Donald C McMillan

Donald C McMillan

University Department of Surgery, Royal Infirmary, Glasgow, UK

Search for more papers by this author
Colin S McArdle

Colin S McArdle

University Department of Surgery, Royal Infirmary, Glasgow, UK

Search for more papers by this author
Wilson J Angerson

Wilson J Angerson

University Department of Surgery, Royal Infirmary, Glasgow, UK

Search for more papers by this author
John H Anderson

John H Anderson

University Department of Surgery, Royal Infirmary, Glasgow, UK

Search for more papers by this author
Paul G Horgan

Paul G Horgan

University Department of Surgery, Royal Infirmary, Glasgow, UK

Search for more papers by this author
Ruth F McKee

Ruth F McKee

University Department of Surgery, Royal Infirmary, Glasgow, UK

Search for more papers by this author
First published: 19 November 2007
Citations: 29
Dr Donald C McMillan, University Department of Surgery, Glasgow G31 2ER, UK. Email: [email protected]

Abstract

Aim: To examine the relationship between tumor diameter, C-reactive protein concentrations and survival in patients undergoing surgery for colorectal cancer.

Method: Tumor diameter and pathological characteristics of the resected specimen were assessed in 227 patients. Circulating concentrations of C-reactive protein were measured prior to surgery.

Results: Ninety-six patients had an elevated C-reactive protein concentration (>10 mg/L) prior to surgery. Tumor size was associated with an elevated C-reactive protein concentration (P < 0.001). C-reactive protein concentrations (P < 0.001) were associated with poorer cancer-specific survival.

Conclusion: Prior to surgery, the maximal tumor diameter is associated with an elevated preoperative C-reactive protein concentration but not survival in patients with primary operable colorectal cancer.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.